Decitabine monohydrate is the hydrated form of Decitabine, a cytidine analog that works as a DNA methyltransferase inhibitor. It incorporates into DNA and inhibits DNA methylation, leading to reactivation of silenced genes and apoptosis in malignant cells. It is grouped under the following drug class(es): Sickle cell agents. Its therapeutic use is listed as antineoplastics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Dacogen. Its PubChem CID is 66601416.
Decitabine monohydrate
| CAS No | 135567-49-6 |
|---|---|
| Molecular Formula | C8H14N4O5 |
| Molecular Weight | 246.22 g/mol |
| Synonyms | 4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one;hydrate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Decitabine monohydrate is the hydrated form of Decitabine, a cytidine analog that works as a DNA methyltransferase inhibitor. It incorporates into DNA and inhibits DNA methylation, leading to reactivation of silenced genes and apoptosis in malignant cells.
The listed CAS number is 135567-49-6.
The listed molecular formula is C8H14N4O5.
The listed molecular weight is 246.22 g/mol.
4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one;hydrate.
The source lists Dacogen.